When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNMSF - FDA OKs J&J's Darzalex in first-line multiple myeloma
Genmab A/S Dkk
The FDA approves Johnson & Johnson (JNJ-0.5%) unit Janssen Biotech's Darzalex (daratumumab), combined with Celgene's Revlimid (lenalidomide) and dexamethasone, for the first-line treatment of multiple myeloma (MM) patients who are ineligible for autologous stem cell transplantation.
More news on: Johnson & Johnson, Genmab A/S, Healthcare stocks news,